Skip to main content
. Author manuscript; available in PMC: 2019 Sep 14.
Published in final edited form as: N Engl J Med. 2019 Mar 14;380(11):1043–1052. doi: 10.1056/NEJMsa1807069

Figure 2. Incidence of Long-Duration or High-Dose Initial Opioid Prescriptions (July 2012–December 2017).

Figure 2.

Shown is the percentage of enrollees who received a long-duration (>3-day and >7-day supply) or high-dose (≥50 and ≥90 morphine milligram equivalents [MME] per day) initial opioid prescription in each month from July 2012 through December 2017. The denominator was 63,817,512 enrollees (mean, 15,897,673 per month) who had not used opioids, among whom 10,874,869 were identified as having received an initial opioid prescription during this period. The dashed and solid vertical lines represent when the CDC issued opioid-prescribing guidelines in draft form and final version, respectively. The inset shows the same data on an enlarged y axis.